The US hedge fund, run by billionaire Paul Singer, has bought a sizeable stake in GSK thanks to in part to its slumping share price in recent months, and has been grumbling about the direction ...

Vaxxas, a clinical-stage biotechnology company, today announced the appointments of three globally respected vaccine experts as advisors to its product development and strategy team as the company ...

Berenberg Bank analyst Kerry Holford maintained a Hold rating on The Estée Lauder Companies (EL – Research Report) yesterday and set a price ...

Eight new members have been appointed to the Council that advises the Prime Minister and Cabinet on science and technology.

Clinical-stage biotechnology company Vaxxas has appointed three global vaccine experts as advisors as it progresses its ...

The Hailie Smartinhaler device has also been cleared for use with inhalers from other manufacturers, including GSK, Boehringer Ingelheim ... Adherium’s chief executive, Dr Paul Mastoridis ...

Slaughter and May has named a successor to managing partner Deborah Finkler. David Johnson is set to take the helm of the ...

Join a community that has been informed and inspired for over 60 years. The Sacramento Observer is more than a newspaper; it's a cornerstone of the community. Your support fuels our ability to deliver ...

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and cancer drugs will make ...

Following FS Investments' plan to relocate, Ensemble Investments is a year away from having a vacant 80,000-square-foot ...

Novartis has become the latest drugmaker to get in trouble over an employee’s LinkedIn likes. The U.K. | Novartis has become ...

European shares were flat in early trade on Wednesday, as gains led by healthcare stocks following drugmaker Novo Nordisk's ...